sb 203580 has been researched along with Urogenital Prolapse in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, YS; Feng, W; Hua, KQ; Wang, XJ | 1 |
1 other study(ies) available for sb 203580 and Urogenital Prolapse
Article | Year |
---|---|
Advanced glycation end products decrease collagen I levels in fibroblasts from the vaginal wall of patients with POP via the RAGE, MAPK and NF-κB pathways.
Topics: Aged; Case-Control Studies; Cell Proliferation; Collagen Type I; Female; Fibroblasts; Gene Expression Regulation; Glycation End Products, Advanced; Humans; Imidazoles; Matrix Metalloproteinase 1; Middle Aged; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Pelvic Organ Prolapse; Primary Cell Culture; Proline; Pyridines; Receptor for Advanced Glycation End Products; RNA, Small Interfering; Signal Transduction; Thiocarbamates; Tissue Inhibitor of Metalloproteinase-1; Uterus; Vagina | 2017 |